CD44 and breast cancer: BAG3 significantly promoted BCSC-like properties as evidenced by increase in the fraction of CD44+/CD24− subpopulation (Figure 3f), as well as a significant increase in the number and size of mammospheres derived from breast cancer cells (Figures 3g and h).